Germline pathogenic variants identified in women with ovarian tumors
Natalie J. Carter(UPMC Health System), Kathleen S. Hruska, Kristin K. Zorn(University of Pittsburgh), Lauren Yackowski, Lisa R. Susswein, Susan Hiraki(Albert Einstein College of Medicine), Rebecca I. Torene(Geisinger Medical Center), Megan L. Marshall(St Mark's Hospital), Benjamin D. Solomon(National Human Genome Research Institute), Patricia D. Murphy(Newark Beth Israel Medical Center), Zhixiong Xu, Kevin J. Arvai, Rachel T. Klein, Anna K. McGill
Cited by 59
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963
Evidence for 28 genetic disorders discovered by combining healthcare and research data
|Nature|2020|672
Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries
|Cell|2012|598
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
|Genetics in Medicine|2015|292
Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers
|Clinical Cancer Research|2005|194